Cue Biopharma Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
0.75
-0.03
(-3.68%)
Volume:
159,546
52 week range:
0.45 - 1.99
Market Cap:
56.588M
Company Description:
Cue Biopharma, Inc. develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers.